Tokyo Tape
Sign in
← Seikagaku

Quarterly report · Q1

4548.TEDINET S100RLV9
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥9.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥33.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥8.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥2.0bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥2.0bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.7bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.9bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.5bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥77.1bnat 2023-06-30Cons.Assets
Total assets¥75.6bnat 2023-03-31Cons.Assets
Total assets¥75.0bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-06-30Cons.Liabilities
Total liabilities¥8.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥69.6bnat 2023-06-30Cons.Net assets
Net assets / equity¥67.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥67.3bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥20.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥23.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥34.622023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.492022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.622022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio90.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.8%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-06-30¥327m
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-06-30¥971m
—segment totalrevenue2023-04-01 → 2023-06-30¥9.7bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥9.7bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00970-000LALreportable segmentsegment profit2022-04-01 → 2022-06-30¥899m
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-06-30¥227m
—segment totalrevenue2022-04-01 → 2022-06-30¥8.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥8.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 382
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember5488000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember2819000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember8307000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration8307000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember5488000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember2819000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember8307000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration8307000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember227000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember899000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember1126000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember－JPY
Operating incomePrior1YTDDuration1126000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember7172000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember2488000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember9661000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration9661000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember7172000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember2488000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember9661000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration9661000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00970-000PharmaceuticalReportableSegmentsMember971000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00970-000LALReportableSegmentsMember327000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember1298000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration1298000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-09
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第78期第１四半期（自 2023年4月1日　至 2023年6月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)生化学工業株式会社
Company name in english cover pageFilingDateInstantSEIKAGAKU CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　水谷　建
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内一丁目6番1号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（5220）8950（代表）

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass